• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov4
Analyst Miehm Gives Aurinia Pharmaceuticals a Modest Buy Rating
21:56
Aurinia Pharma released FY2025 Q3 earnings on November 4 Pre-Market (EST), actual revenue USD 73.47 M (forecast USD 67.7 M), actual EPS USD 0.23 (forecast USD 0.16)
14:30
Aurinia Pharma released FY2025 9 Months Earnings on November 4 Pre-Market (EST), with actual revenue of USD 205.94 M and EPS of USD 0.5495
14:30
Aurinia Pharmaceuticals Reports Q3 Financial Results
11:00
Nov3
Aurinia Pharmaceuticals Expects EPS of 16 Cents
13:46
Sep30
Aurinia Pharmaceuticals Responds to FDA's Post About Drug Withdrawal
00:27

Schedules & Filings

Schedules
Filings
Nov4
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 73.47 M, Net Income 31.55 M, EPS 0.23

Jul31
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 70.01 M, Net Income 21.51 M, EPS 0.1595

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 62.47 M, Net Income 23.34 M, EPS 0.16

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
385.000
+173.05%
+244.000
GURE
10.200
+115.19%
+5.460
TGL
13.830
+104.65%
+7.072
WHLR
6.338
+95.62%
+3.190
TDIC
0.4154
+47.93%
+0.136
IRBT
4.205
+38.78%
+1.173
PRAX
253.000
+33.18%
+63.235
DBRG
12.715
+30.81%
+2.990
YYAI
1.350
+29.81%
+0.310
CHPT
10.840
+27.23%
+2.320
View More